Additive antitumour response to the rabbit VX2 hepatoma by combined radio frequency ablation and toll like receptor 9 stimulation

Radiofrequency Ablation of Liver Tumors in Combination with Local OK-432 Injection Prolongs Survival and Suppresses Distant Tumor Growth in the Rabbit Model with Intra- and Extrahepatic VX2 Tumors

(2013) Ken Kageyama et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Radiofrequency Ablation and Immunostimulant OK-432: Combination Therapy Enhances Systemic Antitumor Immunity for Treatment of VX2 Lung Tumors in Rabbits

(2013) Shinichi Hamamoto et al.   RADIOLOGY

The future of CpG immunotherapy in cancer

(2012) Behnam Badie et al.   Immunotherapy

Hsp70, a messenger from hyperthermia for the immune system

(2011) Anna Jolesch et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

CpG DNA as a vaccine adjuvant

(2011) Christian Bode et al.   Expert Review of Vaccines

Time-Course Studies of Implanted Rabbit VX2 Liver Tumors to Identify the Appropriate Time for Starting Hepatic Arterial Embolization in Animal Models

(2011) Akinaga Sonoda et al.   ONCOLOGY

Combination strategies for enhancing the efficacy of immunotherapy in cancer patients

(2010) Federica Moschella et al.   Annals of the New York Academy of Sciences

Prolonged recurrence-free survival following OK432-stimulated dendritic cell transfer into hepatocellular carcinoma during transarterial embolization

(2010) Y. Nakamoto et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Therapeutic Cancer Vaccines in Combination with Conventional Therapy

(2010) Mads Hald Andersen et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Immunotherapy for Melanoma: Current Status and Perspectives

(2010) Doru T. Alexandrescu et al.   JOURNAL OF IMMUNOTHERAPY

Dendritic cell vaccination in human melanoma: relationships between clinical effects and vaccine parameters

(2010) Noriaki Nakai et al.   Pigment Cell & Melanoma Research

Activation of tumor-specific T lymphocytes after laser-induced thermotherapy in patients with colorectal liver metastases

(2009) Thomas Josef Vogl et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Phase I study of TLR9 agonist PF-3512676 in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer

(2009) Kazuhiko Yamada et al.   CANCER SCIENCE

Dendritic cell-based therapeutic cancer vaccines: what we have and what we need

(2009) Pawel Kalinski et al.   Future Oncology

CD40-Independent Engagement of Mammalian hsp70 by Antigen-Presenting Cells

(2009) R. J. Binder   JOURNAL OF IMMUNOLOGY

Increased Immunostimulatory Activity Conferred to Antigen-presenting Cells by Exposure to Antigen Extract From Hepatocellular Carcinoma After Radiofrequency Thermal Ablation

(2009) Alessandro Zerbini et al.   JOURNAL OF IMMUNOTHERAPY

Abrogation of Local Cancer Recurrence After Radiofrequency Ablation by Dendritic Cell-based Hyperthermic Tumor Vaccine

(2009) Qiong Liu et al.   MOLECULAR THERAPY

Radiofrequency Ablation Induces Antigen-presenting Cell Infiltration and Amplification of Weak Tumor-induced Immunity

(2009) Sergio A. Dromi et al.   RADIOLOGY

Radiofrequency Ablation and Chemoembolization for Hepatocellular Carcinoma

(2008) Christos S. Georgiades et al.   CANCER JOURNAL

Toll-like receptor ligand activation of murine bone marrow-derived dendritic cells

(2008) Rebecca J. Dearman et al.   IMMUNOLOGY

Randomized Phase II Trial of a Toll-Like Receptor 9 Agonist Oligodeoxynucleotide, PF-3512676, in Combination With First-Line Taxane Plus Platinum Chemotherapy for Advanced-Stage Non–Small-Cell Lung Cancer

(2008) Christian Manegold et al.   JOURNAL OF CLINICAL ONCOLOGY

Immunization With Analog Peptide in Combination With CpG and Montanide Expands Tumor Antigen-specific CD8+ T Cells in Melanoma Patients

(2008) Julien Fourcade et al.   JOURNAL OF IMMUNOTHERAPY

Liver cirrhosis

(2008) Detlef Schuppan et al.   LANCET

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE